Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions.

AIDS (London, England) - 13 Jun 2003

Halfon Philippe, Durant Jacques, Clevenbergh Philippe, Carsenti Hélène, Celis Linda, Khiri Hacene, De Smet Koen, De Brauwer Annelies, Hulstaert Frank, Dellamonica Pierre

Abstract excerpt

OBJECTIVE: To monitor the disappearance of resistance-associated mutations and reappearance of wild-type (WT) virus during structured treatment interruptions (STI) using DNA sequencing and line probe assay. METHODS: Eleven HIV-1-infected patients participating in the MUTAVIR study undergoing a 3-month STI after multi-HAART failure were monitored biweekly. Genotypes were assessed by sequencing and VERSANT HIV-1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Codon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Viral

Share to Genome, Viral

Share to HIV Infections

Share to Treatment Failure

Share to Viral Load

Source

Identifiers

PMID: 12799556
DOI: 10.1097/00002030-200306130-00009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions.PMID 12799556Read ↗

Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacity.Semantic proximity Read ↗

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.Semantic proximity Read ↗

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.Semantic proximity Read ↗

Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.Semantic proximity Read ↗

Mutation takes no vacation: can structured treatment interruptions increase the risk of drug-resistant HIV-1?Semantic proximity Read ↗

Drug resistance mutations during structured treatment interruptions.Semantic proximity Read ↗

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.Semantic proximity Read ↗

Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.Semantic proximity Read ↗

Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.Semantic proximity Read ↗

Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors.Semantic proximity Read ↗

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.Semantic proximity Read ↗

Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.